Literature DB >> 8417026

Growth of Helicobacter pylori in media containing cyclodextrins.

R Olivieri1, M Bugnoli, D Armellini, S Bianciardi, R Rappuoli, P F Bayeli, L Abate, E Esposito, L de Gregorio, J Aziz.   

Abstract

We show that solid and liquid media, supplemented only with cyclodextrins and free of blood and its derivatives, support the growth of Helicobacter pylori. These media can be used for primary isolation of the bacteria from biopsy samples, routine laboratory growth, and large-scale industrial fermentation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417026      PMCID: PMC262644          DOI: 10.1128/jcm.31.1.160-162.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  3 in total

1.  Unsaturated fatty acids and viability of Helicobacter (Campylobacter) pylori.

Authors:  S L Hazell; D Y Graham
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

Review 2.  Helicobacter pylori and the pathogenesis of gastroduodenal inflammation.

Authors:  M J Blaser
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

3.  Growth of Campylobacter pylori in liquid media.

Authors:  D R Morgan; R Freedman; C E Depew; W G Kraft
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

  3 in total
  31 in total

1.  In vitro activity of a novel antimicrobial agent, TG44, for treatment of Helicobacter pylori infection.

Authors:  Osamu Kamoda; Kinsei Anzai; Jun-ichi Mizoguchi; Masatoshi Shiojiri; Toshiharu Yanagi; Takeshi Nishino; Shigeru Kamiya
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Serum-free culture of H pylori intensifies cytotoxicity.

Authors:  Hiroyuki Ohno; Akiyuki Murano
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

3.  Unique susceptibility of Helicobacter pylori to simethicone emulsifiers in alimentary therapeutic agents.

Authors:  A V Kane; A G Plaut
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

Review 4.  Diagnosis of Helicobacter pylori.

Authors:  U Blecker; D I Mehta
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

5.  Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin.

Authors:  Z Xiang; S Censini; P F Bayeli; J L Telford; N Figura; R Rappuoli; A Covacci
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Bisulfite or sulfite inhibits growth of Helicobacter pylori.

Authors:  S J Hawrylik; D J Wasilko; S L Haskell; T D Gootz; S E Lee
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

7.  Growth of Helicobacter pylori in medium supplemented with cyanobacterial extract.

Authors:  Alba E Vega; Teresa I Cortiñas; Claudia M Mattana; Humberto J Silva; Olga Puig De Centorbi
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Comparative evaluation of three supplements for Helicobacter pylori growth in liquid culture.

Authors:  Masoumeh Douraghi; Samaneh Saberi Kashani; Hojjat Zeraati; Maryam Esmaili; Akbar Oghalaie; Marjan Mohammadi
Journal:  Curr Microbiol       Date:  2009-12-01       Impact factor: 2.188

9.  Iron-repressible outer membrane proteins of Helicobacter pylori involved in heme uptake.

Authors:  D J Worst; B R Otto; J de Graaff
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Helicobacter pylori: a eubacterium lacking the stringent response.

Authors:  G L Scoarughi; C Cimmino; P Donini
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.